China Medical Device Registration for Foreign Brands: NMPA Class I–III Pathways

Q: "Do all medical devices need NMPA registration before entering China?"

"No — only Class II and Class III devices require registration (注册) with the NMPA. Class I devices need only a lighter filing (备案) with the provincial medical products administration. The decisive factor is risk class, not the fact that the product is a 'device', so map every SKU to its class before you plan the launch clock."

Q: "Can a foreign manufacturer register a device in China without a local entity?"

"Yes, but you must appoint a China agent for registration affairs. Under the 2021 NMPA registration and filing measures, the overseas manufacturer is the registrant of record, while a China-established agent lodges and maintains the dossier and carries local regulatory accountability. A Hong Kong importer of record such as GOODSINFINITE can also anchor import and bonded fulfilment without you incorporating in mainland China."

Q: "How long does NMPA Class III device registration take?"

"Plan 12–24 months for a typical Class III device, because higher-risk devices commonly require clinical evaluation or trials under the NMPA framework. Class II registration usually runs 6–12 months, and Class I filing can clear in weeks once the dossier and quality-system documents are in place. Run the clock in parallel with store and marketing setup, never after it."

Q: "Is clinical evaluation always required for imported devices?"

"No. NMPA exempts many devices through its catalogue of products exempt from clinical evaluation, and some Class II devices qualify for a literature- or bench-based evaluation instead of trials. Class III devices and novel high-risk products are the ones most likely to need full clinical trials, which is what pushes their timelines past a year."

Q: "Can I sell medical devices in China through cross-border e-commerce first?"

"Sometimes. A limited set of medical and health devices appears on the cross-border e-commerce retail import positive list maintained by China's commerce, customs and finance authorities, and those may be imported through the 1210 bonded channel without full domestic registration. Anything outside the list must follow the standard NMPA registration route before it can be sold in China."

Why medical devices deserve their own registration playbook

Generic "China product registration" advice fails medical device brands because this category runs on a completely different rulebook from cosmetics or food. Devices are classified by risk, not by product family, and the approval path ranges from a weeks-long filing to a multi-year registration with clinical trials. A European or American manufacturer that assumes its device clears like a cosmetic will usually discover the gap at the port — or worse, after a distributor has already taken orders. This guide sets out how China's NMPA registers and files foreign devices, which class your product sits in, and how long the clock really runs.

12–24 monthsTypical NMPA Class III medical device registration window for a foreign manufacturer, including clinical evaluationSource: NMPA Medical Device Registration framework (State Council Order No. 680, 2017; implementing Measures No. 47/48 effective 1 October 2021)

China medical device registration is the NMPA pre-market approval a foreign manufacturer must obtain before a Class II or Class III device can be legally imported, sold, or used in mainland China

China medical device registration (医疗器械注册) is the pre-market approval issued by the National Medical Products Administration that authorizes a specific device — by model and intended use — to be placed on the Chinese market. It is distinct from customs clearance: clearance moves a shipment across the border, while registration confers the legal right for that device to be sold at all. The system is set out in the Regulation on the Supervision and Administration of Medical Devices (State Council Order No. 680, effective 1 May 2017) and its implementing measures (NMPA). For a foreign brand, registration is therefore the gate that determines whether your goods can enter the country legally, and it must start long before any freight is booked.

The three-class system sorts devices by risk, and the class decides your entire timeline

The three-class system is the backbone of Chinese device regulation, and it is where every launch plan should begin.

Class I (low risk) — such as simple non-invasive instruments — require only a filing (备案) with the provincial medical products administration. This is the fast lane.
Class II (medium risk) — such as many diagnostic and physical-therapy devices — require registration (注册) with the NMPA and commonly need technical review.
Class III (high risk) — such as implantable, life-supporting, or novel devices — require full NMPA registration and are the most likely to need clinical trials.

The practical difference in effort is large:

	Class I	Class II	Class III
Route	Filing (备案)	Registration (注册)	Registration (注册)
Authority	Provincial MPA	NMPA	NMPA
Clinical evaluation	Generally not required	Often exempt or literature-based	Commonly required
Realistic timeline	Weeks	~6–12 months	~12–24 months

Classifying a device correctly is not a formality — misclassifying a Class III as Class II is one of the most expensive errors a foreign manufacturer can make, because the dossier, testing and clinical strategy are entirely different.

The overseas manufacturer is the registrant, but a China agent for registration affairs must lodge the file

Foreign medical device registration follows a sponsor model. The overseas manufacturer is the registrant of record (注册人), but China requires the appointment of a China-established agent for registration affairs (医疗器械注册代理人) that lodges and maintains the dossier and carries local regulatory accountability. Under the 2021 NMPA implementing measures (Orders No. 47 and 48, effective 1 October 2021), the overseas manufacturing enterprise must also be registered with the NMPA as a manufacturing site (NMPA). A Hong Kong or mainland importer of record — such as GOODSINFINITE TRADE LIMITED — can act as that local anchor so a brand does not need to incorporate in mainland China on day one, while a dedicated registration agent handles the technical submission.

Clinical evaluation is required for higher-risk devices and is what stretches Class III timelines past a year

Clinical evaluation (临床评价) is the process of demonstrating a device's safety and performance, and it is where the biggest schedule risk sits. NMPA exempts many products through its catalogue of devices exempt from clinical evaluation, and some Class II devices can use a literature- or bench-based evaluation instead of trials. Class III devices and novel high-risk products are the ones most likely to require full clinical trials, which is the single factor that pushes their timelines into the 12–24 month range (NMPA). Building the clinical strategy into the plan from month one — not after the dossier is written — is what separates a 14-month launch from a 30-month one.

Timelines you should plan around, and how they interact with channel choice

Registration clocks vary by class and by how much testing and clinical evidence your device already holds:

Class I filing: often weeks once quality-system and labelling documents are ready.
Class II registration: commonly 6–12 months including technical review and any required testing.
Class III registration: typically 12–24 months where clinical trials are needed.

Registrations also carry validity and renewal obligations, and overseas manufacturers must demonstrate conformance with China's medical device good-manufacturing-practice expectations, usually supported by a home-country certificate of free sale or GMP certificate. Run the registration clock in parallel with your cross-border store setup and marketing work, never after it — the generic China product registration roadmap covers how the lanes differ across categories.

The cross-border channel can be a bridge, but only for listed devices

Because full registration takes years for high-risk devices, the commercially sensible sequence for some brands is to enter through cross-border e-commerce retail import first. A limited set of medical and health devices appears on the cross-border e-commerce retail import positive list maintained by China's commerce, customs and finance authorities (MOFCOM), and those may be imported through the 1210 bonded channel without full domestic registration, provided the product is on the list. Everything outside the list must follow the standard NMPA route before it can be sold in China. Our guide to the 1210 bonded import model explains the bonded mechanics.

Common medical device registration mistakes

Misclassifying the risk class. Treating a Class III as Class II compresses a 12–24 month plan into a 6-month assumption and produces a refused submission.
Starting registration after onboarding. Because Class III clocks run past a year, registration must start before — not after — platform and distributor work.
Assuming one approval covers the range. A portfolio spans several classes; map every SKU separately, because the dossier and clinical requirement differ per class.
Skipping label and advertising review. Chinese device labelling and advertising rules are strict and sit with the market regulator (SAMR); fix them before production, not at the border.

How GOODSINFINITE supports device registration

We bundle the regulatory and logistics work so a brand enters cleanly:

Class mapping. We confirm the risk class and the right lane (filing vs. registration) for each SKU, and start the correct process immediately.
Importer of record. GOODSINFINITE holds the China import qualification and can anchor 1210 bonded shipments without you incorporating locally.
Dossier and agent coordination. We pre-review labels and assemble NMPA-ready dossiers and coordinate the China registration agent.
Bonded fulfilment across five cities (Tianjin, Shanghai, Ningbo, Guangzhou, Qingdao) for rapid domestic delivery once clearance is granted.

Enter China the way compliant device brands do: map the class, secure the right registration or filing, and let a qualified importer carry the shipment across the border.

FAQ

Do all medical devices need NMPA registration before entering China? No — only Class II and Class III devices require registration (注册) with the NMPA. Class I devices need only a lighter filing (备案) with the provincial medical products administration. The decisive factor is risk class, not the fact that the product is a device.

Can a foreign manufacturer register a device in China without a local entity? Yes, but you must appoint a China agent for registration affairs. Under the 2021 NMPA measures the overseas manufacturer is the registrant of record, while a China-established agent lodges and maintains the dossier and carries local accountability. A Hong Kong importer of record can also anchor import and bonded fulfilment without you incorporating in mainland China.

How long does NMPA Class III device registration take? Plan 12–24 months for a typical Class III device, because higher-risk devices commonly require clinical evaluation or trials. Class II registration usually runs 6–12 months, and Class I filing can clear in weeks once the dossier and quality-system documents are in place.

Is clinical evaluation always required for imported devices? No. NMPA exempts many devices through its catalogue of products exempt from clinical evaluation, and some Class II devices qualify for a literature- or bench-based evaluation. Class III devices and novel high-risk products are the ones most likely to need full clinical trials.

Can I sell medical devices in China through cross-border e-commerce first? Sometimes. A limited set of medical and health devices appears on the cross-border e-commerce retail import positive list, and those may be imported through the 1210 bonded channel without full domestic registration. Anything outside the list must follow the standard NMPA registration route.